Allen Andrew R
- SEC CIK
- 0001374539
No open-market purchases or sales filed in the past year.
Current role at each company
- CGEM Cullinan Therapeutics, Inc.Directoras of Jun 18, 2026
- ADAPY Adaptimmune Therapeutics PLCDirectoras of Jul 1, 2024
- GRTS Gritstone bio, Inc.PRESIDENT AND CEOas of Jun 26, 2024
- TCRR TCR2 Therapeutics Inc.Directoras of Jun 1, 2023
- SRRA Sierra Oncology, Inc.Director, 10% Owneras of Jul 1, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Allen Andrew R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GRTS Gritstone bio, Inc.
PRESIDENT AND CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2024 (view filing) | May 16 | 1 day | Allen Andrew RPRESIDENT AND CEO | SSale | −24.3K | $0.75 | −$18.2K | −2.4%985.4K after |